Literature DB >> 17348244

Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables.

Suparaporn Wangkaew1, Nuntana Kasitanon, Chate Sivasomboon, Ramjai Wichainun, Waraporn Sukitawut, Worawit Louthrenoo.   

Abstract

This study was performed to determine the prevalence of ocular and oral sicca symptoms in Thai patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and scleroderma (Scl). The ocular symptoms and sign (the Schirmer's 1 test) and the oral sicca symptoms and sign (the Saxon's test) in each of 50 RA, SLE and Scl patients were compared with their age-matched controls. The correlation between the presence of sicca symptoms and signs with their clinical activity was also determined. Ocular sicca symptoms were found more common in patients with RA (38% vs 18%, p < 0.05), SLE (36% vs 14%, p < 0.05) and Scl (54% vs 16%, p < 0.01), and oral sicca symptoms were found more common in SLE (22% vs 0%, p < 0.01), and Scl (16% vs 4%, p < 0.05) than their controls. However, only RA patients had a significantly higher proportion of positive Schimer-1 test compared with their controls (p < 0.01). There was no strong correlation between sicca symptoms or signs and other clinical or laboratory variables (age, disease duration, disease activity, disease severity, and antibody to Ro and La antigens) in these three groups. In conclusion, sicca symptoms were seen significantly more common in Thai patients with connective tissue diseases, but the symptoms did not show a good correlation with the clinical and laboratory variables.

Entities:  

Mesh:

Year:  2006        PMID: 17348244

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  8 in total

1.  Evaluation of dry eye signs and symptoms in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

2.  Anterior Segment Optical Coherence Tomography of Tear Film and Cornea in Systemic Lupus Erythematosus Patients.

Authors:  Mohamed Salah El-Din Mahmoud; Mohamed A Hamid; Mohamed Farouk Abdelkader
Journal:  Clin Ophthalmol       Date:  2021-08-12

3.  Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis.

Authors:  Aniko Rentka; Annamaria Nagy; Jolan Harsfalvi; Gabriella Szucs; Zoltan Szekanecz; Rudolf Gesztelyi; Peter Szodoray; Adam Kemeny-Beke
Journal:  Rheumatol Int       Date:  2017-09-07       Impact factor: 2.631

Review 4.  An insight into rheumatology in Thailand.

Authors:  Worawit Louthrenoo
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

5.  Relationships between activated dendritic cells and dry eye symptoms and signs.

Authors:  Harry Levine; Jodi Hwang; Harrison Dermer; Divy Mehra; William Feuer; Anat Galor
Journal:  Ocul Surf       Date:  2021-06-06       Impact factor: 6.268

6.  Dry eye and corneal langerhans cells in systemic lupus erythematosus.

Authors:  Miklós D Resch; László Marsovszky; János Németh; Márta Bocskai; László Kovács; Attila Balog
Journal:  J Ophthalmol       Date:  2015-03-29       Impact factor: 1.909

7.  Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity.

Authors:  Caterina Gagliano; Elisa Visalli; Mario Damiano Toro; Roberta Amato; Giovanni Panta; Davide Scollo; Giovanni Scandura; Salvatore Ficili; Giorgio Amato; Alessia Benenati; Roberta Foti; Giulia Malaguarnera; Giuseppe Gagliano; Raffaele Falsaperla; Teresio Avitabile; Rosario Foti
Journal:  Diagnostics (Basel)       Date:  2020-06-13

8.  Reduced salivary flow and caries status are correlated with disease activity and severity in patients with diffuse cutaneous systemic sclerosis.

Authors:  Katica Parat; Mislav Radić; Dijana Perković; Dolores Biočina Lukenda; Dusanka Martinović Kaliterna
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.